Articles
FDA knocks back QRxPharma's MoxDuo again
QRxPharma (ASX:QRL) will need to resubmit its FDA application for MoxDuo IR again, after the regulator issued a second Complete Response Letter. [ + ]
University of Adelaide ‘braggs’ about transdisciplinary facility
In July 2013, following the award of $29 million from the Education Investment Fund, ‘The Braggs’ was officially opened. Named after University of Adelaide alumni Sir William Henry Bragg and his son, Sir William Lawrence Bragg, the $100 million building is the home of the Institute for Photonics and Advanced Sensing (IPAS). [ + ]
Allied Healthcare gets CE Mark for CardioCel
After securing regulatory approval, Allied Healthcare (ASX:AHZ) now expects to start selling its CardioCel heart patch in Europe in calendar Q4. [ + ]
Hypertension drugs increase the effect of chemo in childhood cancer
Beta-blockers are traditionally used in the treatment of high blood pressure, but researchers at the Children’s Cancer Institute Australia (CCIA) have found that they can also increase the effectiveness of chemotherapy in treating aggressive childhood cancers such as neuroblastoma. [ + ]
Ascend gears up for cancer immunotherapy trials
Ascend Biopharmaceuticals CEO Clement Leong details the company’s plans for Australian clinical trials of its key products, a cancer vaccine and an oncolytic virus. [ + ]
Trials in autoimmune disease
Giving children their own cord blood to prevent them getting type 1 diabetes and development of a new immunotherapy are part of a more tailored approach to treating autoimmune diseases. [ + ]
Genes, male beauty and attractiveness to the other gender
It’s a simple fact: some individuals are more attractive to the opposite sex than others. But what makes them more desirable? [ + ]
Prime Minister announces Medical Technologies Innovation Partnership
Prime Minister Kevin Rudd last week announced the Medical Technologies Innovation Partnership - the first of the Australian Innovation Partnership program. The program is intended to create partnerships between government, business and the research community that will create new high-skill jobs for the future. [ + ]
Consultation on cost recovery for gene technology regulator
The Department of Health and Ageing (DoHA) is undertaking an assessment and development of a cost recovery model for services provided by the Office of the Gene Technology Regulator (OGTR). DoHA has engaged PricewaterhouseCoopers (PwC) to undertake an economic analysis of the gene technology sector, and PwC is seeking input from sector stakeholders through the stakeholder survey. [ + ]
So you’re thinking of buying a LIMS
A good laboratory information management system (LIMS) can make a huge improvement to a laboratory’s productivity. [ + ]
Following the herd: the influence of online ratings
The comments section of online news sites is intended to be a place where everyone can express their own opinion. But according to a study published in the journal Science, many people are heavily influenced by the positive opinions of others in such outlets, while less swayed by the negative ones. [ + ]
Mimicking a cure
A collaboration of Melbourne scientists who describe themselves as a “happy confluence” is shedding much-needed light on how the body controls nervous system myelination, and how their tiny peptide ‘mimic’ could help patients with neurodegenerative disease. [ + ]
CSL boosts FY13 profit by 19%
CSL (ASX:CSL) recorded 19% higher profit for FY13 as well as 7% higher revenue, and has announced the appointment of a new director. [ + ]
AmpliPhi presents CF lung data at phage summit
AmpliPhi BioSciences has used the Evergreen International Phage Meeting to present data supporting the effectiveness of bacteriophage treatments in P. aeruginosa infections. [ + ]
One chemical - two crystal colours
A surprise for chemists studying agostic bonds was the development of crystals of two different colours from one chemical in one flask. [ + ]